According to the DSIR website there are more than one thousand companies across all industries, including research labs set up by multinational companies which are recognized by DSIR in India. Within the pharma and biotech space, there are less than two hundred companies which got DSIR recognition .Genome Life Science is now a part of this selective group and one of the handful companies in bioinformatics and system biology space in India.

In-house R&D units recognized by DSIR in the area of biotechnology sector enables the company to enjoy a weighted tax deduction on its R &D expenses along with complete exemption of duties on import of materials , equipment and machinery for R&D purpose This recognition provides eligibility to obtain the financial assistance from various Govt. agencies.
GLS, a R&D operation of Genome International Corporation USA, a pioneer in next generation biomarker discovery and bioinformatics research. GLS was established in 2004 with the vision of developing innovative technology, Bioinformatics algorithms, tools, and databases for biomarker discovery in the areas of healthcare, veterinary, agriculture, food and related industries. The company provides life science databases of unique content developed with data mining algorithms along with their interactive and dynamic user interfaces. In addition, it provides data analysis products/services for the analysis of Next Generation Sequencing (NGS) data generated from all major platforms such as Illumina GA/HiSeq, ABI SOLiD, and Roche 454.

GLS is a provider of start-to-finish Next-Generation Sequencing and data analysis services, custom database development, contract research and bioinformatics consulting. GLS helps customers worldwide meet the bioinformatics challenges with its powerful tools and technologies.